Combination of an inhibitor of inducible nitric oxide synthase (iNOS) and an antiinflammatory agent, e.g. a corticosteroid

摘要

The invention relates to a pharmaceutical composition comprising a preferential inhibitor of inducible nitric oxide synthase over constitutive nitric oxide synthase and an anti-inflammatory agent for the therapeutic treatment of the pathological consequences of systemic inflammatory response syndrome, a process for its preparation and its use.